Schedule 13G ownership disclosure

JAZZ PHARMACEUTICALS PLC

Security class unavailable · CUSIP: G50871105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,987,399
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001243448-18-000004
Form type
SC 13G/A
Filer
Jazz Pharmaceuticals plc
CIK
CIK 1232524
Filed
Jul 10, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub